Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results
Prenetics Global Limited (NASDAQ: PRE) announced that CEO Danny Yeung and CFO Brian Rosin purchased $1.0 million in company shares during August 2026, bringing cumulative leadership investment to $3.75 million since November 2025. The purchases follow strong Q2 2026 results with total revenue up 288% YoY to $46.5 million, IM8 revenue reaching $45.0 million (up 359% YoY), and the company achieving its first month of positive consolidated Adjusted Free Cash Flow in July. Prenetics raised FY 2026 revenue guidance to $220-230 million and introduced FY 2027 guidance of over $400 million.